ATE305299T1 - Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen - Google Patents
Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungenInfo
- Publication number
- ATE305299T1 ATE305299T1 AT02746098T AT02746098T ATE305299T1 AT E305299 T1 ATE305299 T1 AT E305299T1 AT 02746098 T AT02746098 T AT 02746098T AT 02746098 T AT02746098 T AT 02746098T AT E305299 T1 ATE305299 T1 AT E305299T1
- Authority
- AT
- Austria
- Prior art keywords
- medication
- treatment
- production
- chronic obstructive
- airway disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001222768 | 2001-07-24 | ||
| PCT/JP2002/007221 WO2003009844A1 (en) | 2001-07-24 | 2002-07-16 | Use of thiazole deirvatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE305299T1 true ATE305299T1 (de) | 2005-10-15 |
Family
ID=19056195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02746098T ATE305299T1 (de) | 2001-07-24 | 2002-07-16 | Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20040147563A1 (de) |
| EP (1) | EP1411936B1 (de) |
| KR (1) | KR100566709B1 (de) |
| CN (1) | CN1267097C (de) |
| AR (2) | AR036179A1 (de) |
| AT (1) | ATE305299T1 (de) |
| BR (1) | BR0208719A (de) |
| CA (1) | CA2441804C (de) |
| DE (1) | DE60206391T2 (de) |
| DK (1) | DK1411936T3 (de) |
| ES (1) | ES2249596T3 (de) |
| HK (1) | HK1077216A1 (de) |
| MX (1) | MXPA04000620A (de) |
| MY (1) | MY128711A (de) |
| TW (1) | TWI302456B (de) |
| WO (1) | WO2003009844A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI394753B (zh) * | 2006-03-17 | 2013-05-01 | Otsuka Pharma Co Ltd | 新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體 |
| TWI436761B (zh) * | 2006-06-19 | 2014-05-11 | Otsuka Pharma Co Ltd | 使用噻唑衍生物之方法 |
| BRPI0909288A2 (pt) * | 2008-03-14 | 2015-08-18 | Otsuka Pharma Co Ltd | Inibidores da mmp-2 e/ou da mmp-9 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69132006T2 (de) | 1990-11-30 | 2000-08-03 | Otsuka Pharma Co Ltd | Thiazolederivate als inhibitoren von aktivem sauerstoff |
| AU4015497A (en) * | 1996-08-26 | 1998-03-19 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Thiazole derivatives useful as selective inhibitors of pde-iv |
| MY128323A (en) * | 1996-09-30 | 2007-01-31 | Otsuka Pharma Co Ltd | Thiazole derivatives for inhibition of cytokine production and of cell adhesion |
| US6727364B2 (en) * | 2001-04-30 | 2004-04-27 | The Procter & Gamble Company | Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
-
2002
- 2002-07-16 AT AT02746098T patent/ATE305299T1/de active
- 2002-07-16 US US10/478,471 patent/US20040147563A1/en not_active Abandoned
- 2002-07-16 WO PCT/JP2002/007221 patent/WO2003009844A1/en active IP Right Grant
- 2002-07-16 DK DK02746098T patent/DK1411936T3/da active
- 2002-07-16 KR KR1020037014359A patent/KR100566709B1/ko not_active IP Right Cessation
- 2002-07-16 MX MXPA04000620A patent/MXPA04000620A/es active IP Right Grant
- 2002-07-16 CA CA002441804A patent/CA2441804C/en not_active Expired - Fee Related
- 2002-07-16 ES ES02746098T patent/ES2249596T3/es not_active Expired - Lifetime
- 2002-07-16 DE DE60206391T patent/DE60206391T2/de not_active Expired - Lifetime
- 2002-07-16 BR BR0208719-7A patent/BR0208719A/pt not_active Application Discontinuation
- 2002-07-16 CN CNB02807386XA patent/CN1267097C/zh not_active Expired - Fee Related
- 2002-07-16 EP EP02746098A patent/EP1411936B1/de not_active Expired - Lifetime
- 2002-07-18 AR ARP020102695A patent/AR036179A1/es not_active Application Discontinuation
- 2002-07-18 TW TW091116029A patent/TWI302456B/zh not_active IP Right Cessation
- 2002-07-19 MY MYPI20022737A patent/MY128711A/en unknown
-
2005
- 2005-10-20 HK HK05109340A patent/HK1077216A1/xx not_active IP Right Cessation
-
2007
- 2007-06-08 US US11/760,345 patent/US7932276B2/en not_active Expired - Fee Related
-
2013
- 2013-04-05 AR ARP130101121A patent/AR090619A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60206391D1 (de) | 2006-02-09 |
| CN1267097C (zh) | 2006-08-02 |
| MXPA04000620A (es) | 2004-06-25 |
| US20040147563A1 (en) | 2004-07-29 |
| KR100566709B1 (ko) | 2006-04-03 |
| TWI302456B (en) | 2008-11-01 |
| US20080081828A1 (en) | 2008-04-03 |
| DE60206391T2 (de) | 2006-07-13 |
| CN1633295A (zh) | 2005-06-29 |
| WO2003009844A1 (en) | 2003-02-06 |
| CA2441804C (en) | 2007-05-08 |
| EP1411936A1 (de) | 2004-04-28 |
| MY128711A (en) | 2007-02-28 |
| AR036179A1 (es) | 2004-08-18 |
| ES2249596T3 (es) | 2006-04-01 |
| EP1411936B1 (de) | 2005-09-28 |
| DK1411936T3 (da) | 2005-12-27 |
| BR0208719A (pt) | 2004-07-20 |
| KR20040028749A (ko) | 2004-04-03 |
| CA2441804A1 (en) | 2003-02-06 |
| AR090619A2 (es) | 2014-11-26 |
| US7932276B2 (en) | 2011-04-26 |
| HK1077216A1 (en) | 2006-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE448219T1 (de) | Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen | |
| DE60320007D1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| ATE430569T1 (de) | Neue arzneimittel zur behandlung von chronisch obstruktiver lungenerkrankung | |
| NO20033594L (no) | Fenetanolamin-derivater for behandling av luftveissykdommer | |
| ATE417606T1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
| ATE484494T1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| ATE344253T1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| DE502006002956D1 (de) | Neues 1,4-benzothiazepin-1,1-dioxidderivat mit verbesserten eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung | |
| ATE367162T1 (de) | Verwendubg von 3-hydroxy-3-methylglutaryl coenzym a reduktase inhibitoren zur herstellung eines medikaments zur behandlung der diabetischen neuropathie | |
| DE50207943D1 (de) | Kristallines anticholinergikum, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels | |
| NO20054640D0 (no) | Fremgangsmater for behandling av Parkinsons sykdom | |
| NO20043000L (no) | Et preparat for behandling av nevrocerebrovaskulaere sykdommer | |
| DE50201306D1 (de) | Verfahren zur kontinuierlichen herstellung inhalierfähiger arzneistoffe | |
| ZA200701584B (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| DE60318839D1 (de) | 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten | |
| ATE548032T1 (de) | Verwendung von chlorguanabenzderivaten zur behandlung von mit polyglutaminexpansion assoziierten erkrankungen | |
| DE60112431D1 (de) | Verwendung von biguanidederivaten zur herstellung eines vernarbungsfördernden medikaments | |
| DE60318327D1 (de) | Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe | |
| HUP0100080A2 (hu) | Mirtazapin alkalmazása alvásiapnoe kezelésére szolgáló gyógyszerkészítmény előállítására | |
| ATE407671T1 (de) | Verwendung von sulfonamid-derivate zur herstellung eines medikaments für die vorbeugung oder behandlung von essstörungen | |
| ATE359285T1 (de) | Verwendung von scopinester derivaten zur herstellung von arzneimitteln | |
| DE60128911D1 (de) | Verwendung von l-threo-methylphenidat zur herstellung eines medikamentes zur behandlung von psychischen erkrankungen | |
| ATE305299T1 (de) | Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen | |
| DE50107692D1 (de) | Verwendung von selenithältigen wässerigen lösungen zur herstellung eines medikaments zur behandlung viraler erkrankungen und pigmentflecken | |
| ATE424195T1 (de) | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1411936 Country of ref document: EP |